浙江省海洋生物医药产业竞争力与发展对策

打开文本图片集

中图分类号：F205；P7

文献标志码：A

文章编号：1005-9857（2026）04-0132-10

Competitiveness and Development Countermeasures of the Marine Biomedicine Industry in Zhejiang Province

（1. Second Institute of Oceanography， MNR， Hangzhou 310012， China; 2. Key Laboratory of Marine Spatial Resource Management Technology， MNR， Hangzhou 310012， China; 3. Zhejiang Institute of Oceanography， Hangzhou 310007， China）

Abstract： Against the backdrop of the rapid development of the global health industry， the marine biomedicine industry， as an important form of new quality productive forces， has demonstrated unique advantages in anticancer drugs， functional foods， health products and other fields， showing great development potential and market prospects. Based on the entropy-weighted TOPSIS method， this paper evaluates the competitiveness of the marine biomedicine industry in coastal cities of Zhejiang Province from 2013 to 2022， and uses the location quotient method to measure its industrial agglomeration level. The results show that， driven by policy support and technological innovation， the agglomeration effect of the marine biomedicine industry in Zhejiang has been significantly enhanced. However， insufficient technological innovation competitiveness， the need for further deepening of the industrial chain， and obvious differences in industrial agglomeration still constrain the further development of the industry. Based on these findings， this paper proposes countermeasures such as enhancing technological innovation capacity， deepening industrial chain integration， and optimizing agglomeration effects， so as to promote the high-quality development of the marine biomedicine industry in Zhejiang Province.

Keywords： Marine biomedicine; Industrial competitiveness; Entropy-weighted TOPSIS; Development countermeasures

0 引言

海洋生物资源具有独特的化学结构和生物活性，在抗癌药物、抗菌剂、免疫调节剂以及功能性食品开发等领域展现出广阔的应用前景[1-3]。（剩余14218字）